Nuubo Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Later Stage VC
- Investors
-
14
Nuubo General Information
Description
Developer of a cardiac monitoring device designed to provide a new perspective on remote and wireless cardiological monitoring. The company's device captures electrocardiograms in dynamic environments in a continuous and non-invasive way through an innovative system based on new-generation biomedical textiles, enabling patients to monitor heart rates that are easy to use and can be worn even while outdoors.
Contact Information
Website
www.nuubo.comCorporate Office
- Paseo de la Castellana, 200
- D510 Edificio Spaces
- 28046 Madrid
- Spain
Corporate Office
- Paseo de la Castellana, 200
- D510 Edificio Spaces
- 28046 Madrid
- Spain
Nuubo Timeline
Nuubo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 30-May-2024 | Completed | Generating Revenue | |||
| 10. Equity Crowdfunding | 08-Apr-2024 | Completed | Generating Revenue | |||
| 9. Later Stage VC | Cancelled | Generating Revenue | ||||
| 8. Later Stage VC (Series A) | 18-Oct-2022 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 03-Nov-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 30-Dec-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 12-Feb-2019 | Completed | Generating Revenue | |||
| 4. Debt - General | 01-Nov-2017 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 02-Aug-2016 | $2.52M | $5.72M | Completed | Generating Revenue | |
| 2. Later Stage VC (Series A) | 23-Apr-2015 | $3.2M | $3.2M | Completed | Generating Revenue |
Nuubo Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 53,753 | $0.978330 | $64.86 | $64.86 | 1x | $64.86 | 6.62% | |
| Ordinary | 71,805 | $0.978330 | $71.42 | $71.42 | 1x | $71.42 | 8.84% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nuubo Comparisons
Industry
Financing
Details
Nuubo Competitors (12)
One of Nuubo’s 12 competitors is BodiMetrics, a Venture Capital-Backed company based in Manhattan Beach, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BodiMetrics | Venture Capital-Backed | Manhattan Beach, CA | ||||
| Vios Medical | Formerly VC-backed | Saint Paul, MN | ||||
| Ten3T Healthcare | Venture Capital-Backed | Bangalore, India | ||||
| Retia Medical | Venture Capital-Backed | White Plains, NY | ||||
| Current Health | Formerly VC-backed | Edinburgh, United Kingdom |
Nuubo Patents
Nuubo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2908664-T3 | Ectopic heartbeat classification system and procedure | Active | 22-Jun-2017 | ||
| EP-3641628-B1 | System and method for classifying ectopic cardiac beats | Active | 22-Jun-2017 | ||
| AU-2018287078-A1 | System and methods for classifying arrhythmia-related heartbeats | Inactive | 22-Jun-2017 | ||
| EP-3641628-A1 | System and methods for classifying arrhythmia-related heartbeats | Active | 22-Jun-2017 | ||
| US-10383539-B2 | System and methods for classifying arrhythmia-related heartbeats | Active | 22-Jun-2017 |
Nuubo Signals
Nuubo Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| INNVIERTE SICC | Government | Minority | ||
| Biozell Ventures | Corporate Venture Capital | Minority | ||
| Dosbio50 | Venture Capital | Minority | ||
| European Union | Government | Minority | ||
| Inside Heart | Corporation | Minority |
Nuubo FAQs
-
When was Nuubo founded?
Nuubo was founded in 2005.
-
Where is Nuubo headquartered?
Nuubo is headquartered in Madrid, Spain.
-
What is the size of Nuubo?
Nuubo has 31 total employees.
-
What industry is Nuubo in?
Nuubo’s primary industry is Monitoring Equipment.
-
Is Nuubo a private or public company?
Nuubo is a Private company.
-
What is Nuubo’s current revenue?
The current revenue for Nuubo is .
-
How much funding has Nuubo raised over time?
Nuubo has raised $27.4M.
-
Who are Nuubo’s investors?
INNVIERTE SICC, Biozell Ventures, Dosbio50, European Union, and Inside Heart are 5 of 14 investors who have invested in Nuubo.
-
Who are Nuubo’s competitors?
BodiMetrics, Vios Medical, Ten3T Healthcare, Retia Medical, and Current Health are some of the 12 competitors of Nuubo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process